文献
J-GLOBAL ID:202202268178332411
整理番号:22A0550595
免疫チェックポイント阻害剤を完成し,疾患進行のない中止後の持続性応答を達成した進行および/または転移性非小細胞肺癌患者における長期転帰:多施設,実世界データ(KCSG LU20-11)【JST・京大機械翻訳】
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11)
著者 (13件):
Kim Hongsik
(Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea)
,
Kim Dong-Wan
(Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea)
,
Kim Miso
(Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea)
,
Lee Youngjoo
(Division of Hematology-Oncology, Department of Medicine, National Cancer Center, Goyang, Republic of Korea)
,
Ahn Hee Kyung
(Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea)
,
Cho Jang Ho
(Division of Oncology, Department of Internal Medicine, Incheon St. Mary’s Hospital, Catholic University of Korea, Incheon, Republic of Korea)
,
Kim Il Hwan
(Division of Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae-Paik Hospital, Busan, Korea)
,
Lee Yun-Gyoo
(Division of Hematology-Oncology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea)
,
Shin Seong-Hoon
(Division of Hematology-Oncology, Department of Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea)
,
Park Song Ee
(Division of Hematology-Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea)
,
Jung Jiyoon
(Division of Hematology-Oncology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea)
,
Kang Eun Joo
(Division of Hemato-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea)
,
Ahn Myung-Ju
(Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
128
号:
4
ページ:
778-787
発行年:
2022年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)